Volver al Panel






Medpace Holdings, Inc. (MEDP)
Valores intradiarios en tiempo real
Resumen del Mercado
From:
To:
MEDP Intraday
No data available
SímboloMEDP
Fecha de SalidaAug 11, 2016
CEODr. August James Troendle M.D.
Empleados a Tiempo Completo6.6k
SectorHealthcare
IndustriaDiagnostics & Research
PaísUnited States
BolsaNasdaqGS
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
Rendimiento
| Período | Rentabilidad % | Cambio de Valor |
|---|---|---|
| 1 Día | +2.32% | +15.16 US$ |
| 5 Días | +8.19% | +50.65 US$ |
| 1 Mes | +8.42% | +51.97 US$ |
| 6 Meses | +62.99% | +258.58 US$ |
Analizando el Mercado con IA
Evaluando los últimos 30 días de historial y métricas fundamentales de MEDP...
Estadísticas Clave
Cap. de Mercado
18.72B
Relación P/E
37.16
Rend. de Div.
0.00%
Máx. 52 Semanas
$684.52
Mín. 52 Semanas
$373.00
Consenso de Analistas
CONSENSOMantener
ALCISTA214.3%
NEUTRAL1178.6%
BAJISTA17.1%
Objetivos de Precios de Analistas a 52 Semanas
Objetivo Mín.
$370.00
$370.00
Objetivo Máx.
$730.00
$730.00
Actual$669.12
Objetivo Prom.$644.77
Recomendaciones de Analistas
Precio Objetivo:$644.77($370.00 - $730.00)
Pensamientos de la Comunidad
Comparta su análisis y sentimiento sobre MEDP
Únase a la comunidad para compartir su análisis
Últimas Noticias para MEDP

MEDP Q3 deep dive: bookings strength drives growth, margin expansion continues
StockStory•23 oct 2026, 23:20
Medpace's Bookings, Pre-Backlog Trends Support Growth Outlook, UBS Says
MT Newswires•23 oct 2026, 18:42
UBS Adjusts Price Target on Medpace to $700 From $673, Maintains Neutral Rating
MT Newswires•23 oct 2026, 13:40

Dow Jones Futures Fall After Moderna Crashes, Meta Fuels AI Meltdown. Warren Buffett Market Is Thriving.
Investor's Business Daily•23 oct 2026, 12:14

5 revealing analyst questions from Medpace’s Q3 earnings call
StockStory•23 oct 2026, 11:12
Truist Securities Adjusts Price Target on Medpace Holdings to $633 From $609, Keeps Hold Rating
MT Newswires•23 oct 2026, 09:45

Does Medpace Holdings (MEDP) Leave Any Room For Cash Flow Upside?
Simply Wall St.•23 oct 2026, 06:17

Medpace: 3 Key Takeaways for Long-Term Investors
Motley Fool•23 oct 2026, 04:11

Medpace Holdings (MEDP) Beat Q3 Estimates, Is It Still 24% Overvalued?
Simply Wall St.•22 oct 2026, 22:10
Medpace Holdings Inc (MEDP) (Q3 2026) Earnings Call Highlights: Record Awards and Margin ...
GuruFocus.com•22 oct 2026, 21:04